NH
Nihon Kohden Corporation
NHNKY · OTC
$10.28 +1.38% (+$0.14)
1M +5.85%
Market Cap ¥513.7B
P/E Ratio 37.44x
Div. Yield 1.77%
ROE 7.81%
Bulios Fair Price
$5.43
47.2% downside
Current Price
$10.28
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NHNKY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
7/9Valuation
37 /100
Fair P/E 37.44x
EV/EBITDA 20.11x
P/FCF 29.07x
Growth
18 /100
Declining EPS growth 15.01%
Rev. growth 3.19%
Book val. growth 4.71%
Profitability
53 /100
Moderate Gross margin 51.99%
Net margin 5.84%
FCF margin 7.52%
Quality
42 /100
Average ROIC 5.71%
ROE 7.81%
Asset turnover 0.96x
Debt
100 /100
Low Debt/Equity 0.14x
Current ratio 3.98x
Net debt/EBITDA -1.11x
Stability
86 /100
Stable Beta 0.38x
Rev. volatility 3.67%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NHNKY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Hirokazu Ogino
Employees
6,116
Headquarters
Tokyo
Upcoming events
09 NOV
Earnings
Upcoming earnings report